These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 7531851)
1. Age-related behavioural, neurochemical and radioligand binding changes in the central 5-HT system of Sprague-Dawley rats. Robson L; Gower AJ; Kendall DA; Marsden CA Psychopharmacology (Berl); 1993; 113(2):274-81. PubMed ID: 7531851 [TBL] [Abstract][Full Text] [Related]
2. Characterization of the 5-HT receptor subtypes involved in the motor behaviours produced by intrathecal administration of 5-HT agonists in rats. Fone KC; Robinson AJ; Marsden CA Br J Pharmacol; 1991 Jun; 103(2):1547-55. PubMed ID: 1832068 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats. Kleven MS; Assié MB; Koek W J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338 [TBL] [Abstract][Full Text] [Related]
4. Effect of isolation rearing on 5-HT agonist-induced responses in the rat. Wright IK; Ismail H; Upton N; Marsden CA Psychopharmacology (Berl); 1991; 105(2):259-63. PubMed ID: 1839066 [TBL] [Abstract][Full Text] [Related]
5. Effects of cold stress on some 5-HT1A, 5-HT1C and 5-HT2 receptor-mediated responses. Zamfir O; Broqua P; Baudrie V; Chaouloff F Eur J Pharmacol; 1992 Aug; 219(2):261-9. PubMed ID: 1385172 [TBL] [Abstract][Full Text] [Related]
6. Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice. Berendsen HH; Broekkamp CL Br J Pharmacol; 1990 Nov; 101(3):667-73. PubMed ID: 2150180 [TBL] [Abstract][Full Text] [Related]
7. Effects of corticosterone on 5-HT1A and 5-HT2 receptor binding and on the receptor-mediated behavioral responses of rats. Takao K; Nagatani T; Kitamura Y; Yamawaki S Eur J Pharmacol; 1997 Aug; 333(2-3):123-8. PubMed ID: 9314024 [TBL] [Abstract][Full Text] [Related]
8. The 5-HT1A receptor full agonist, 8-OH-DPAT inhibits ACTH-induced 5-HT2A receptor hyperfunction in rats: involvement of 5-HT1A receptors in the DOI-induced wet-dog shakes in ACTH-treated rats. Kitamura Y; Kitagawa K; Fujitani Y; Shibata K; Araki H; Sendou T; Gomita Y Biol Pharm Bull; 2007 Jan; 30(1):117-20. PubMed ID: 17202670 [TBL] [Abstract][Full Text] [Related]
9. Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine. Wieland S; Kreider MS; McGonigle P; Lucki I Brain Res; 1990 Jun; 520(1-2):291-302. PubMed ID: 1698505 [TBL] [Abstract][Full Text] [Related]
10. Behavioural and neurochemical evidence for the decrease of brain extracellular 5-HT by the antidepressant drug tianeptine. Datla KP; Curzon G Neuropharmacology; 1993 Sep; 32(9):839-45. PubMed ID: 7694170 [TBL] [Abstract][Full Text] [Related]
11. The effects of long-term treatment with the 5-HT1A receptor agonist 8-OH-DPAT and the 5-HT2/1C receptor agonist DOI in the neonatal rat. Johansson-Wallsten CE; Berg M; Meyerson BJ Eur J Pharmacol; 1993 Oct; 243(2):149-54. PubMed ID: 8276064 [TBL] [Abstract][Full Text] [Related]
12. Different effects on the responses of functional pre- and postsynaptic 5-HT1A receptors by repeated treatment of rats with the 5-HT1A receptor agonist 8-OH-DPAT. Larsson LG; Rényi L; Ross SB; Svensson B; Angeby-Möller K Neuropharmacology; 1990 Feb; 29(2):85-91. PubMed ID: 1691832 [TBL] [Abstract][Full Text] [Related]
13. Effect of selective serotonin agonists on basal, corticotrophin-releasing hormone- and vasopressin-induced ACTH release in vitro from rat pituitary cells. Calogero AE; Bagdy G; Moncada ML; D'Agata R J Endocrinol; 1993 Mar; 136(3):381-7. PubMed ID: 8386213 [TBL] [Abstract][Full Text] [Related]
14. Effects of the serotonin1A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin on neurochemical responses to stress. Saphier D; Welch JE J Neurochem; 1995 Feb; 64(2):767-76. PubMed ID: 7530293 [TBL] [Abstract][Full Text] [Related]
15. Chronic, combined treatment with desipramine and mianserin: enhanced 5-HT1A receptor function and altered 5-HT1A/5-HT2 receptor interaction in rats. Lund A; Mjellem N Pharmacol Biochem Behav; 1993 Aug; 45(4):777-83. PubMed ID: 8415816 [TBL] [Abstract][Full Text] [Related]
16. The effects of Ca2+ antagonists and hydralazine on central 5-hydroxytryptamine biochemistry and function in rats and mice. Green AR; DeSouza RJ; Davies EM; Cross AJ Br J Pharmacol; 1990 Jan; 99(1):41-6. PubMed ID: 1691944 [TBL] [Abstract][Full Text] [Related]
17. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin. Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561 [TBL] [Abstract][Full Text] [Related]
19. Effect of reserpine on behavioural responses to agonists at 5-HT1A, 5-HT1B, 5-HT2A, and 5-HT2C receptor subtypes. Heslop KE; Curzon G Neuropharmacology; 1999 Jun; 38(6):883-91. PubMed ID: 10465692 [TBL] [Abstract][Full Text] [Related]
20. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors. Goodwin GM; Green AR Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]